Clinical presentation of DFNA11 (MYO7A).
Clinical presentation of DFNA11 (MYO7A).
复制标题
DFNA11 (MYO7A) 的临床表现。
DOI:
10.1159/000066808
复制
发表时间:
2002
影响因子:
--
通讯作者:
K. Ichimura
中科院分区:
文献类型:
--
作者:
Y. Tamagawa;K. Ishikawa;Kotaro Ishikawa;T. Ishida;K. Kitamura;S. Makino;T. Tsuru;K. Ichimura
Recent studies of hereditary hearing impairment have shown some cases where different mutations in the same gene can lead to either dominant or recessive inheritance and either syndromic or nonsyndromic hearing impairment. Mutations in the myosin VIIA gene (MYO7A) are responsible for Usher syndrome type Ib (USH1B)[1], an autosomal recessive nonsyndromic hearing impairment (DFNB2)[2, 3], and an autosomal dominant nonsyndromic hearing impairment (DFNA11)[4]. While most MYO7A mutations cause the USH1B phenotype, some cause DFNB2, and one causing DFNA11 has been reported. The USH1B phenotype includes profound congenital hearing loss with retinitis pigmentosa beginning in childhood and is associated with profound vestibular dysfunction. The DFNB2 phenotype is profound hearing loss with variable age at onset and some vestibular dysfunction. This chapter presents the DFNA11 phenotype in a Japanese family which, to our knowledge, is the only one to show autosomal dominant nonsyndromic hearing impairment caused by a mutation in MYO7A [5, 6].